surpass 3 tirzepatide Once-weekly versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase trial Tirzepatide Significantly Reduced A1C and

Frontiers in Pharmacology, 14 , Article 1226528

Cholesterol Lowering and Heart Disease Prevention Atorvastatin significantly reduces LDL cholesterol while also helping to raise HDL (good cholesterol)

Pens vs Vials Facts: Both pens and vials can maintain stability when properly formulated, stored, and used as directed

We tried using lizard DNA that was in the freezer in Toronto at the Royal Ontario Museum and the cloning didnt work

When side effects occur, they're typically mild and short-lived

Researchers have been examining other potential health benefits from GLP-1 agonist medications outside of type 2 diabetes management and weight loss